Dual time point 18F-FDG PET/CT imaging identifies bilateral renal tuberculosis in an immunocompromised patient with an unknown primary malignancy

Infection and Chemotherapy

Volumn 47, Issue 2, 2015, Pages 117-119

  Subramanyam, Padma ^a   Palaniswamy, Shanmuga Sundaram ^a  

^a AMRITA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Dual time point imaging; FDG PETCT; Metastatic adrenal and skeletal deposits; Renal tuberculosis; Unknown primary

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18; GLUCOSE; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; BILATERAL RENAL TUBERCULOSIS; BONE LESION; CANCER CHEMOTHERAPY; CANCER OF UNKNOWN PRIMARY SITE; CANCER SCINTISCANNING; CANCER STAGING; CASE REPORT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DISTANT METASTASIS; DRUG CLEARANCE; DUAL TIME POINT IMAGING; EXTRAPULMONARY TUBERCULOSIS; GLUCOSE TRANSPORT; HISTOLOGY; HUMAN; HUMAN TISSUE; IMAGING; IMMUNOCOMPROMISED PATIENT; INFLAMMATORY CELL; KIDNEY SCINTISCANNING; KIDNEY TUBERCULOSIS; MALE; MIDDLE AGED; TIME; WHOLE BODY CT; WHOLE BODY PET;

EID: 84936950244     PISSN: 20932340     EISSN: 20926448     Source Type: Journal    
DOI: 10.3947/ic.2015.47.2.117     Document Type: Article

References (2)

1. 18F-FDG PET imaging for differentiating malignant from inflammatory processes. J Nucl Med 2001;42:1412-7.
2. Kubota K, Itoh M, Ozaki K, Ono S, Tashiro M, Yamaguchi K, Akaizawa T, Yamada K, Fukuda H. Advantage of delayed whole-body FDG-PET imaging for tumour detection. Eur J Nucl Med 2001;28:696-703.